Viewing nowESO Tablet 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 201405109 · Approved 2014.10.31 · Insurance code 649404670
Treatment of acid-related disorders (e.g., reflux, ulcers); adjunctive treatment for Helicobacter pylori eradication; prevention of ulcers and rebleeding
This medication is used to treat gastroesophageal reflux disease and erosive esophagitis, and it helps prevent recurrence in patients with esophagitis and alleviates symptoms in those with gastroesophageal reflux disease without esophagitis. It is also effective in treating and preventing recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection, in combination with antibiotics. This medication is used for the treatment and prevention of gastric ulcers and duodenal ulcers related to gastrointestinal symptoms occurring during nonsteroidal anti-inflammatory drug use. It is also used in the treatment of Zollinger-Ellison syndrome and as maintenance therapy to prevent rebleeding from gastric or duodenal ulcers. Overall, this medication is effective in treating and preventing various symptoms and diseases related to gastrointestinal disorders.
This drug should be swallowed with a liquid such as water and should not be chewed or crushed. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent symptoms may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. No clinical trials have been conducted for more than 4 weeks. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4–8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80–160 mg per day. Doses above 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. Elderly: No dose adjustment is necessary.
Adolescents 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents 12 years and older - Once symptoms have resolved, subsequent symptoms may be controlled by administering 20 mg once daily. Adolescents 12 years and older - In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Children under 12 years: There is no experience with administering this drug to children under 12 years of age.
This medication should not be used by patients who are allergic to this drug, its components, or benzimidazole derivatives, or have a history of hypersensitive reactions. Additionally, patients who are allergic to penicillins or macrolide antibiotics should not be given this medication when used in combination with amoxicillin or clarithromycin for the eradication of Helicobacter pylori. This medication should also not be used by patients on certain heart-related medications, antiviral agents, or nursing women. Various adverse reactions may occur while taking this medication, with common symptoms including headache, abdominal pain, diarrhea, nausea, and in rare cases, serious side effects such as blood abnormalities, liver function problems, skin rashes, myalgia, and more. Particularly, long-term use may lead to hypomagnesemia or an increased risk of fractures, hence regular monitoring is necessary. This medication can increase the risk of bacterial infections in the gastrointestinal tract by suppressing gastric acid secretion, so if diarrhea persists, consultation with a healthcare professional is necessary. Furthermore, this medication has a high potential for drug interactions, so patients must inform healthcare providers of all medications they are currently taking, and care should be exercised when used concurrently with warfarin, methotrexate, clopidogrel, and others. Its safety during pregnancy has not been sufficiently established, so careful consideration is required, and it should be avoided during breastfeeding. In case of overdose, as there is no specific antidote, appropriate treatment based on symptoms is important. Finally, keep this medication out of reach of children and avoid transferring it to other containers.
Leukopenia, Thrombocytopenia, Agranulocytosis, Pancytopenia, Fever, Angioedema, Anaphylactic reaction, Shock, Peripheral edema, Hyponatremia, Hypomagnesemia, Insomnia, Agitation, Mental confusion, Depression, Aggression, Hallucinations, Headache, Dizziness, Sensory disturbance, Drowsiness, Taste disorder, Blurred vision, Bronchospasm, Pancreatitis, Abdominal pain, Constipation, Diarrhea, Abdominal distension, Nausea, Vomiting, Dry mouth, Stomatitis, Gastrointestinal candidiasis, Microscopic colitis, Increased liver enzymes, Hepatitis, Liver failure, Encephalopathy, Dermatitis, Itching, Rash, Urticaria, Hair loss, Photosensitivity, Erythema multiforme, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Riel syndrome, Acute generalized pustular psoriasis, Drug reaction with eosinophilia and systemic symptoms, Fracture, Arthralgia, Myalgia, Muscle weakness, Interstitial nephritis, Gynecomastia, Asthenia, Increased sweating, Clostridium difficile-associated diarrhea, Abdominal bloating, Allergic reaction, Back pain, Chest pain, Retrosternal pain, Facial edema, Facial flushing, Fatigue, Fever, Influenza-like illness, Generalized edema, Leg edema, Lethargy, Pain, Stiffness, Peripheral edema, Flushing, Hypertension, Tachycardia, Goiter, Irritable bowel syndrome, Worsening constipation, Dyspepsia, Dysphagia, Gastrointestinal malformation, Epigastric pain, Belching, Esophageal disorder, Frequent bowel movements, Gastroenteritis, Gastrointestinal bleeding, Hiccups, Melena, Oral disorders, Pharyngeal disorders, Rectal disorders, Gastrointestinal symptoms, Increased serum gastrin, Tongue disorders, Tongue edema, Ulcerative stomatitis, Earache, Tinnitus, Anemia, Hypopigmented anemia, Cervical lymphadenopathy, Nosebleed, Leukocytosis, Leukopenia, Thrombocytopenia, Hyperbilirubinemia, Liver dysfunction, Increased ALT, Increased AST, Diabetes, Hyperuricemia, Increased ALP, Polydipsia, Vitamin B12 deficiency, Weight gain, Weight loss, Worsening arthritis, Joint disorders, Cramps, Fibromyalgia syndrome, Hernia, Rheumatic polymyositis, Anorexia, Apathy, Increased appetite, Confusion, Worsening depression, Hypertonia, Sensory impairment, Erectile dysfunction, Insomnia, Migraine, Worsening migraine, Sleep disorder, Tremor, Visual field defect, Dysmenorrhea, Menstrual disorders, Vaginitis, Worsening asthma, Cough, Dyspnea, Laryngeal edema, Pharyngitis, Rhinitis, Sinusitis, Acne, Anal itching, Erythematous rash, Papular rash, Otitis media, Abnormal olfaction, Loss of taste, Taste distortion, Urinary abnormalities, Albuminuria, Cystitis, Dysuria, Fungal infection, Hematuria, Frequency of urination, Candidiasis, Genital candidiasis, Polyuria, Conjunctivitis, Visual disturbances, Duodenitis, Esophagitis, Esophageal stricture, Esophageal ulcer, Esophageal varices, Gastric ulcer, Gastritis, Benign polyp or nodule, Barrett's esophagus, Mucosal discoloration, Hernia, Systemic lupus erythematosus, Cutaneous lupus erythematosus, Gastric gland polyp, Hypocalcemia, Hypokalemia, Rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature to preserve the medication's efficacy.
Pink round film-coated tablet
28 tablets (14 tablets/PTP X 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.